Recordati Industria Chimi... (RCDTF)
Recordati Industria Chimica e Farmaceutica S.p.A. Statistics
Share Statistics
Recordati Industria Chimica e Farmaceutica S.p.A. has 206.3M shares outstanding. The number of shares has increased by -0.17% in one year.
Shares Outstanding | 206.3M |
Shares Change (YoY) | -0.17% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | n/a |
FTD / Avg. Volume | n/a |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 26.57 and the forward PE ratio is null. Recordati Industria Chimica e Farmaceutica S.p.A.'s PEG ratio is 3.09.
PE Ratio | 26.57 |
Forward PE | n/a |
PS Ratio | 4.73 |
Forward PS | n/a |
PB Ratio | 5.9 |
P/FCF Ratio | -39.34 |
PEG Ratio | 3.09 |
Enterprise Valuation
Recordati Industria Chimica e Farmaceutica S.p.A. has an Enterprise Value (EV) of 10.77B.
EV / Sales | 4.6 |
EV / EBITDA | 13.53 |
EV / EBIT | 18.89 |
EV / FCF | -38.28 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.61 |
Quick Ratio | 1.06 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.03 |
Debt / FCF | -0.08 |
Interest Coverage | 7.83 |
Financial Efficiency
Return on Equity is 22.19% and Return on Invested Capital is 11.5%.
Return on Equity | 22.19% |
Return on Assets | 8.11% |
Return on Invested Capital | 11.5% |
Revenue Per Employee | $520,925.25 |
Profits Per Employee | $92,660.29 |
Employee Count | 4,495 |
Asset Turnover | 0.46 |
Inventory Turnover | 1.46 |
Taxes
Income Tax | 130.68M |
Effective Tax Rate | 23.88% |
Stock Price Statistics
The stock price has increased by 8.6% in the last 52 weeks. The beta is 0.54, so Recordati Industria Chimica e Farmaceutica S.p.A.'s price volatility has been higher than the market average.
Beta | 0.54 |
52-Week Price Change | 8.6% |
50-Day Moving Average | 54.22 |
200-Day Moving Average | 53.26 |
Relative Strength Index (RSI) | 70.04 |
Average Volume (20 Days) | 33 |
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica S.p.A. had revenue of 2.34B and earned 416.51M in profits. Earnings per share was 2.02.
Revenue | 2.34B |
Gross Profit | 1.6B |
Operating Income | 638.86M |
Net Income | 416.51M |
EBITDA | 795.75M |
EBIT | 628.73M |
Earnings Per Share (EPS) | 2.02 |
Balance Sheet
The company has 322.42M in cash and 22.84M in debt, giving a net cash position of 299.58M.
Cash & Cash Equivalents | 322.42M |
Total Debt | 22.84M |
Net Cash | 299.58M |
Retained Earnings | 2.23B |
Total Assets | 5.13B |
Working Capital | 562.34M |
Cash Flow
In the last 12 months, operating cash flow was 569.92M and capital expenditures -851.16M, giving a free cash flow of -281.24M.
Operating Cash Flow | 569.92M |
Capital Expenditures | -851.16M |
Free Cash Flow | -281.24M |
FCF Per Share | -1.36 |
Margins
Gross margin is 68.34%, with operating and profit margins of 27.28% and 17.79%.
Gross Margin | 68.34% |
Operating Margin | 27.28% |
Pretax Margin | 23.37% |
Profit Margin | 17.79% |
EBITDA Margin | 33.98% |
EBIT Margin | 27.28% |
FCF Margin | -12.01% |
Dividends & Yields
RCDTF pays an annual dividend of $2.03, which amounts to a dividend yield of 2.5%.
Dividend Per Share | $2.03 |
Dividend Yield | 2.5% |
Dividend Growth (YoY) | 21.45% |
Payout Ratio | 89.87% |
Earnings Yield | 3.76% |
FCF Yield | -2.54% |
Analyst Forecast
Currently there are no analyst rating for RCDTF.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 3.74 |
Piotroski F-Score | 7 |